ID: ALA5284517

Max Phase: Preclinical

Molecular Formula: C18H22ClN9O7S

Molecular Weight: 543.95

Associated Items:

Representations

Canonical SMILES:  Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC[C@H](N)C(=O)O)S(=O)(=O)c2cnc(Cl)cn2)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C18H22ClN9O7S/c19-10-3-23-11(4-22-10)36(33,34)27(2-1-8(20)18(31)32)5-9-13(29)14(30)17(35-9)28-7-26-12-15(21)24-6-25-16(12)28/h3-4,6-9,13-14,17,29-30H,1-2,5,20H2,(H,31,32)(H2,21,24,25)/t8-,9+,13+,14+,17+/m0/s1

Standard InChI Key:  NUFHSMQFUWVWAB-ACSHICKMSA-N

Associated Targets(Human)

TRDMT1 Tbio tRNA (cytosine(38)-C(5))-methyltransferase (277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NSUN2 Tbio RNA cytosine C(5)-methyltransferase NSUN2 (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NSUN6 Tbio tRNA (cytosine(72)-C(5))-methyltransferase NSUN6 (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 543.95Molecular Weight (Monoisotopic): 543.1051AlogP: -2.04#Rotatable Bonds: 9
Polar Surface Area: 245.79Molecular Species: ZWITTERIONHBA: 14HBD: 5
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 2.00CX Basic pKa: 9.09CX LogP: -4.88CX LogD: -4.88
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.20Np Likeness Score: 0.13

References

1. Schwickert M, Zimmermann RA, Habeck T, Hoba SN, Nidoieva Z, Fischer TR, Stark MM, Kersten C, Lermyte F, Helm M, Schirmeister T..  (2023)  Covalent S-Adenosylhomocysteine-Based DNA Methyltransferase 2 Inhibitors with a New Type of Aryl Warhead.,  14  (6): [PMID:37312859] [10.1021/acsmedchemlett.3c00062]

Source